Sweet Syndrome after Oxford‐AstraZeneca COVID‐19 Vaccine (AZD1222) in an Elderly Female
Dermatologic therapy(2021)
摘要
Vaccination for COVID19 infection is in full swing all around the world and while the vaccines are considered overall safe, many cutaneous and extracutaneous adverse effects have been reported after their use. Local injection-site reactions are the commonest adverse effect described with the use of these vaccines. We describe a case of Sweet syndrome in an elderly female after the first dose of Oxford-AstraZeneca COVID-19 vaccine (AZD1222).
更多查看译文
关键词
adverse effects,COVID vaccine,skin,Sweet syndrome
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要